2009 annual financial data
Summit Therapeutics 2009 Operating margin
Direct answer
Operating margin was -3,047.57%.
Operating income was -9,202,000 GBP and net income was -5,342,118 GBP.
Operating cash flow was -2,645,620 GBP.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 301,945 GBP
- Operating income
- -9,202,000 GBP
- Net income
- -5,342,118 GBP
- Operating cash flow
- -2,645,620 GBP